Current sensing multiple output current stimulators

Information

  • Patent Grant
  • 11338144
  • Patent Number
    11,338,144
  • Date Filed
    Friday, February 14, 2020
    4 years ago
  • Date Issued
    Tuesday, May 24, 2022
    2 years ago
Abstract
A multiple output current stimulator circuit with fast turn on time is described. At least one pair of input side and output side transistors is arranged in a current mirror connected to a supply transistor by cascode coupling. The output side transistor supplies stimulation current to an electrode in contact with tissue. An operational amplifier connected to a reference voltage and to the output side transistor drives the supply transistor to maintain the voltage at the output side transistor equal to the reference voltage. The at least one pair of transistors includes multiple pairs of transistors whose output side transistors drive respective electrodes with stimulation currents. The stimulator determines the initiation and duration of stimulation current pulses supplied to each electrode. At circuit activation, large currents are generated which discharge capacitances in the output side transistors causing rapid output side transistor turn on.
Description
FIELD OF THE INVENTION

The present invention relates to a current mirror circuit capable of a broad range of uses requiring controlled delivery of electrical current and finding particular utility in functional electrical stimulation (FES) applications.


BACKGROUND OF THE INVENTION

Typically in FES applications, current stimulators are used for providing programmable current pulses directed through an electrode to stimulate targeted neuromuscular tissue. The amplitude and duration of the current pulses delivered through the electrode are usually programmed through a digital to analog converter (DAC). The current output from the DAC is normally amplified to the desired output current amplitude at the current stimulator. The current amplification is typically accomplished using a current mirror circuit and in particular for MOSFET devices, the current gain is achieved by controlling the device semiconductor die width (W) to length (L) ratio (W/L) of the input side and output side transistors of a current mirror. For example, in the prior art current mirror circuit of FIG. 1, the W/L ratios of the input side transistor M1 and the output side transistor M2 determine the overall current gain.


Errors regarding the amplitudes of the current delivered arise mainly due to the finite output impedance of the stimulator and any mismatch errors between the input side transistor M1 and the output side transistor M2. One technique to compensate for the effects of the output impedance of the stimulator is to configure the circuit of FIG. 1 to include transistors MC1 and MC2 in a cascode arrangement in order to increase the output impedance of the stimulator. Typically, to compensate for the mismatch in the input side and output side transistors, the W's and/or L's of the transistors are usually increased. The negative effect however of increasing the device W and L is a marked slow down of the response time of stimulator between turn on to turn off and vice versa by virtue of increased transistor capacitances. This slow down is particularly realized when the stimulator current is programmed for low current amplitudes.


In advanced applications it is contemplated that stimulator output current is to be individually and independently programmed through a plurality of electrodes rather than through just a single electrode. For a candidate circuit as is shown in FIG. 2A, it is contemplated that the cascode transistor may be split into a number of cascode transistors, that is transistors MC(2) to MC(n), supplying output current to respective “loads” and that the overall output current equals the input DAC current times a current gain K. The number of outputs OUT(2) to OUT(n) delivering output current is controllable by switching the gates of the individual cascode transistors to voltage source VBP for turning on a particular transistor and to VS for turning off the particular transistor. In such cases it is likely that individual output currents as well as the overall sum of individual output currents, will vary as a function of different electrode/tissue impedances and the voltages at each of the outputs.


As shown in FIG. 2B, one technique to reduce these variations is to use differential amplifiers or operational amplifiers (op amps) in an attempt to regulate stimulator operation. In such case, one input to the op amp 20 designated as A is the common interconnection of the drains of the cascode transistors MC(2) to MC(n) while another input to the op amp 20 designated as B is a predetermined reference voltage. In operation, the regulated design of FIG. 2B strives to maintain the voltage at input A equal to the voltage at input B for a constant current ID2 flowing through transistor M2 independent of the number of outputs being turned on or off. However this approach could be compromised due to the different loading capacitances and loads coupled to op amp 20 when a different number of electrodes are programmed for current/stimulation delivery. Additionally, long turn on and turn off times are expected especially when relatively small currents are programmed and a large number of electrodes are activated. The situation is compounded especially when using high voltage transistors for the cascode transistors to accommodate high voltages at the outputs. The high voltage transistors usually have high threshold voltages and it normally requires a long time to charge up to the threshold voltage before the transistors turn on. In some instances, what is needed may be a circuit design to improve the output current accuracy for multiple electrode applications without the requirements of continual calibration and a design with less transistor die area. In establishing a current gain K, it may be desirable in at least some instances to avoid dependence on transistor die size to establish the gain and on a more reliable parameter such as resistors.


Furthermore, a design may be helpful in some instances to ensure fast turn on time under different output current levels including small output current delivery conditions especially with a multiplicity of programmable stimulating electrodes that are capable of outputting large current levels. However, in many stimulator designs, the turn on times for delivering small output current levels are usually very long. This is mainly due to the fact that only small currents are available to flow through the transistors for small output current levels to charge the parasitic capacitances of the transistors, especially the gate-to-source capacitances. The turn on times are even longer, especially for high voltage stimulators that can be programmed to have large current outputs. For these high voltage stimulators, very large high voltage transistors are required for the required large output current levels due to the relatively low gain of these transistors. Also, due to the relatively high threshold voltages associated with these high voltage transistors, it will take longer time to have the small current outputs charging up the gate-to-source voltages to higher than the threshold voltages in order to turn on these high voltage transistors.


SUMMARY OF THE INVENTION

One non-limiting embodiment of the present invention includes pairs of transistors, preferably MOSFET transistors, each pair being connected in a current mirror configuration and coupled to a supply transistor in a cascode arrangement. Each pair of transistors has an input side transistor and an output side transistor, the output side transistor of each pair being electrically coupled to a respective and corresponding tissue stimulating electrode. The output side transistors therefore implement a circuit for providing multiple current stimulator capability. The present invention also includes an operational or differential amplifier having one input coupled to a reference voltage and another input coupled to the output side transistors and an output which drives the supply transistor. In steady state, the operational amplifier maintains the voltage at the output side transistor equal to the reference voltage.


In some instances, a current source supplies constant current through a first resistor to establish the reference voltage and a voltage source supplies all the stimulation current through a second resistor to establish the voltage at the output side transistor. A current gain K which represents the factor that multiplies the value of the constant current to provide the total stimulation current is equal to the ratio of the values of the first resistor and the second resistor. In such a manner, the present invention avoids dependency on the MOSFET transistor's width and length values defined in a corresponding semiconductor chip but relies on the more dependable resistor values to achieve the required current gain.


In some instances, advantageously, at circuit turn on, the output of the operational amplifier is very large due to the difference in amplifier input voltages and thus the supply transistor which is driven by the operational amplifier provides large initial currents to discharge the capacitances associated with the output side transistors which results in a major improvement (reduction) in stimulator turn on time almost independent of the number of stimulator outputs.


One embodiment of the present disclosure relates to a peripherally-implantable neurostimulation system. The peripherally-implantable neurostimulation system can include a pulse generator including a reference current generator that generates a reference current, and a multiple output current stimulator circuit. In some embodiments, the multiple output current stimulator circuit can include a current source that can be, for example, connected to the reference current generator. The multiple output current stimulator circuit can include a first resistor coupled to the current source to provide a reference voltage, and at least one output side transistor having a current output terminal for providing an output current. In some embodiments, the multiple output current stimulator circuit can include a second resistor coupled between a voltage source and the at least one output side transistor to thereby provide a common sensing voltage, and a differential amplifier. In some embodiments, the differential amplifier can include a first input coupled to the reference voltage, a second input coupled to the common sensing voltage, and an output arranged to drive the at least one output side transistor as a function of the difference between the reference voltage and the common sensing voltage.


In some embodiments, the peripherally-implantable neurostimulation system can include a lead connected to the pulse generator. This lead can include a plurality of conductive electrodes and plurality of non-conductive regions. In some embodiments of the peripherally-implantable neurostimulation system, the pulse generator can include a plurality of electrical pulse programs that can, for example, affect the frequency and strength of electrical pulses generated by the pulse generator.


In some embodiments, the peripherally-implantable neurostimulation system can include a controller that can communicate with the pulse generator to create one of the plurality of electrical pulse programs and/or a controller that can communicate with the pulse generator to select one of the plurality of electrical pulse programs. In some embodiments, the peripherally-implantable neurostimulation system can include a first switch located between the output of the differential amplifier and the output side transistor. This first switch can be closed according to one of the plurality of electrical pulse programs.


One embodiment of the present disclosure relates to a peripherally-implantable neurostimulation system. The system includes a pulse generator that can generate one or several electrical pulses. The pulse generator can include a current generator that can generate a reference current, and a stimulator that includes a stimulator circuit. In some embodiments, the stimulator circuit amplifies the reference current according to a ratio of resistances of a first resistor and a second resistor. The system can include one or more leads connected to the pulse generator. In some embodiments, the one or more leads can include one or more electrodes and the one or more leads can conduct the one or several electrical pulses from the pulse generator to the one or more electrodes.


In some embodiments of the peripherally-implantable neurostimulation system the stimulator circuit can include a differential amplifier having a first input and a second input. In some embodiments, the first resistor can be coupled to the first input and the second resistor can be coupled to the second input.


In some embodiments the peripherally-implantable neurostimulation system includes a plurality of outputs in electrical connection with the second resistor, and in some embodiments of the system, a stimulator output current flowing through the second resistor is equal to the sum of the current flowing through the outputs. In some embodiments of the peripherally-implantable neurostimulation system, one or both of the first resistor and the second resistor can be a plurality of resistors. In some embodiments of the peripherally-implantable neurostimulation system the plurality of resistors of the first resistor can be arranged in series, and/or in some embodiments, the plurality of resistors of the second resistor can be arranged in parallel.


One embodiment of the present disclosure relates to a peripherally-implantable neurostimulation system. The system includes a pulse generator that can generate one or several electrical pulses. The pulse generator can include a current generator that can generate a reference current, and a stimulator including a stimulator circuit. In some embodiments, the stimulator circuit can include a supply transistor having an output connected to one or several gates of one or several output transistors. The system can include one or more leads connected to the pulse generator, which one or more leads can include one or more electrodes. In some embodiments, the one or more leads can conduct the one or several electrical pulses from the pulse generator to the one or more electrodes.


In some embodiments of the peripherally-implantable neurostimulation system, the drain of the supply transistor can be connected to one or several gates of one or several output transistors. In some embodiments, the peripherally-implantable neurostimulation system can include a differential amplifier. In some embodiments, the output of the differential amplifier can be arranged to drive the supply transistor.


One embodiment of the present disclosure relates to a method of treating neuropathic pain. The method can include implanting a pulse generator in a peripheral portion of a body, which pulse generator can generate one or several electrical pulses. In some embodiments, the pulse generator can include a stimulator circuit that can amplify the reference current according to a ratio of resistances of a first resistor and a second resistor. In some embodiments, the method can include implanting a lead within the peripheral portion of the body, which lead can include one or more electrodes, positioning the one or more electrodes of the lead proximate to a peripheral nerve, and connecting the lead to the pulse generator.


In some embodiments, the method of treating neuropathic pain can further include generating an electrical pulse with the pulse generator; and conducting the electrical pulse to the peripheral nerve with the lead.


One embodiment of the present disclosure relates to a method of treating neuropathic pain. The method can include implanting a pulse generator in a peripheral portion of a body, which pulse generator can generate one or several electrical pulses. In some embodiments, the pulse generator can include a stimulator circuit that can include a supply transistor having an output connected to one or several gates of one or several output transistors. In some embodiments, the method can include implanting a lead within the peripheral portion of the body, which lead can include one or more electrodes, positioning the one or more electrodes of the lead proximate to a peripheral nerve, and connecting the lead to the pulse generator.


In some embodiments, the method of treating neuropathic pain can include generating an electrical pulse with the pulse generator, and conducting the electrical pulse to the peripheral nerve with the lead.


One embodiment of the present disclosure relates to a peripherally-implantable neurostimulation system. The system includes a pulse generator that can generate one or several electrical pulses. The pulse generator can include a current generator that can generate a reference current, and a stimulator that can include a stimulator circuit. In some embodiments, the stimulator circuit has a turn on time of less than 5 us for an output current of less than 50 mA. In some embodiments, the system can include one or more leads connected to the pulse generator. In some embodiments, the one or more leads can include one or more electrodes, which one or more leads can conduct the one or several electrical pulses from the pulse generator to the one or more electrodes.


In some embodiments of the peripherally-implantable neurostimulation system, the turn on time is less than 2 us for an output current between 200 uA and 25 mA. In some embodiments of the peripherally-implantable neurostimulation system, the turn on time is between 0.5 and 2 us for an output current between 200 uA and 25 mA. In some embodiments of the peripherally-implantable neurostimulation system, the pulse generator can generate at least one electrical pulse having a pulse width of 50 us.


One embodiment of the present disclosure relates to a neurostimulation system. The neurostimulation system includes an implantable pulse generator. In some embodiments, the implantable pulse generator includes a first resistance, a reference signal generator that can generate a reference signal, the reference signal being at least one of a reference voltage extending across, or a reference current flowing through the first resistance, and a second resistance. In some embodiments, the neurostimulation system can include a plurality of electrode outputs, and a multi-output stimulator that can amplify the reference signal to a total output signal. In some embodiments, the total output signal can be at least one of a total output voltage or a total output current extending across or flowing through the second resistance. In some embodiments, the multi-output stimulator can distribute the total output signal to at least some of the plurality of electrode outputs. In some embodiments, a gain value of the amplification by the multi-output stimulator is based on the first resistance and the second resistance. In some embodiments, the neurostimulation system can include one or more leads that include a plurality of electrodes that can be coupled to the plurality of electrode outputs.


In some embodiments of the neurostimulation system, the gain value of the amplification by the multi-output stimulator is equal to the first resistance divided by the second resistance. In some embodiments of the neurostimulation system, the first resistance can include a plurality of resistors in series, and in some embodiments, the second resistance can include a plurality of resistors in parallel. In some embodiments of the neurostimulation system, the implantable pulse generator is sized for implantation in a peripheral portion of a human body, and in some embodiments, the peripheral portion of the human body can be one of an arm, a leg, a hand, and a foot.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a single output stimulator circuit using a cascode current mirror configuration of the prior art;



FIG. 2A is a multiple output stimulator circuit using a cascode current mirror;



FIG. 2B is a multiple output stimulator circuit using a regulated cascode current mirror;



FIG. 3 is an overall block diagram of the multiple output current stimulator system of the present invention; and



FIG. 4A is a current sensing multiple output stimulator circuit using an op amp and resistor ratios to produce a desired current gain;



FIG. 4B is a detailed circuit diagram for a current sensing multiple output stimulator circuit of the present invention.



FIG. 5 shows timing diagrams for a multiple output current stimulator with and without the fast turn on time of the present invention.



FIG. 6 is a schematic illustration of one embodiment of a peripherally-implantable neurostimulation system.





DETAILED DESCRIPTION OF THE INVENTION

Referring now to FIG. 3, there is shown an overall block diagram of one example of a multiple output current stimulator system, and specifically, one embodiment of a pulse generator. The system includes both an anodic multiple output stimulator block 10A and a cathodic multiple output stimulator block 10B. The system provides for selecting either an anodic or cathodic stimulator based upon tissue stimulation requirements determined by a clinician. The outputs of the anodic and cathodic stimulators are selected by setting the corresponding “bits” in digital registers 2. Digital registers 2 generate digital control signals DCS, which control the selection of the anodic and cathodic stimulators. Although FIG. 3 discloses two stimulators 10A and 10B, the discussion below with reference to FIGS. 4A and 4B focuses solely on the anodic stimulator 10A. It is to be understood that in some embodiments a complementary circuit for the cathodic stimulator (not shown in FIG. 4A or 4B) functions in accordance with the same principles of operation as does the anodic stimulator and therefore is not included in the following discussion merely for purposes of brevity.


Digital registers 2 also store information regarding stimulation pulse duration, amplitude and profile as well as other operational parameters. Based upon information stored in digital registers 2 and the CLOCK signal, stimulation controller 30 generates the desired stimulation pulse amplitude and triggers digital to analog converter DAC 4 to generate an output. Based upon the DAC 4 output, reference current source generator 6 provides a sink for Isink current (shown as Isink PORT in FIGS. 4A and 4B) for the anodic stimulator and provides a source current Isource for the cathodic stimulator. Stimulation controller 30 generates turn on signal ANO to turn on the anodic stimulator 10A to output anodic current at the selected outputs (OUT(2) to OUT(n) in FIG. 4A and OUT(1) to OUT(n) in FIG. 4B) according to the programmed anodic pulse amplitude, duration and profile. Similarly, stimulation controller 30 also generates turn on signal CAT to turn on cathodic stimulator 10B to output cathodic current at the selected outputs according to the programmed cathodic pulse amplitude, duration and profile.


With reference to FIG. 4A, a schematic illustration of one non-limiting embodiment of the current sensing multiple output current stimulator circuit 11A is shown. As discussed above, FIG. 4A includes only the anodic multiple output stimulator circuit and it is to be understood that a complementary circuit for cathodic stimulation although not shown in FIG. 4A is to be considered as optionally included in the overall circuit and system. Furthermore, it is to be understood that the invention also contemplates the use of a single multiple output stimulator whether it be for anodic or cathodic stimulation. Upon issuance of signal ANO from stimulation controller 30, current, designated as Isink flows through resistor R1 from voltage source VS and a voltage VR1 is generated across resistor R1 by virtue of the current Isink flowing through R1. Reference voltage VREF 14 is generated as a function of current Isink flowing through resistor R1 and is coupled to the positive input of operational amplifier (op amp) 16. Although the voltage VREF is coupled to the positive input of op amp 16, it is to be understood that reconfiguring the circuit connections to apply VREF to the negative input of op amp 16 is within the contemplation of the invention depending upon complementary circuit designs as may occur when using p channel MOSFET transistors in place of n channel transistors. The current Isink is coupled to reference current generator 6 shown in FIG. 3 via Isink PORT, as shown in FIG. 4A.


Advantageously in some instances, in the embodiment depicted in FIG. 4A, instead of relying on transistor W/L ratios for achieving a desired current gain K, current sensing multiple output current stimulator circuit 11A uses resistors R1 and R2 and opamp 16 to control the gate voltages of the cascode transistors MC(2) to MC(n) for achieving an accurate overall stimulator output current IR2.


Circuit 11A further includes at least one transistor. The source of transistor MC(2) is connected to voltage source VS through resistor R2. The source of transistor MC(2) is also connected to the negative input of op amp 16 and provides a sensing voltage to op amp 16. The drain of transistor MC(2), designated as OUT(2), is coupled to a respective electrode (not shown) for delivery of stimulation current to the tissue in contact with such respective electrode.


As further seen, in FIG. 4A, the op amp 16 is directly connected to the gate terminals of MC(2) to MC(n) through a set of switches SA(1) to SA(n) and SB(1) to SB(n). In some embodiments, these switches can be, for example, “single pole single throw switches.” When any of the outputs OUT(2) to OUT(n) are selected to deliver current, the switches SA(1) to SA(n) connected between the op amp 16 output and the corresponding gate terminals of MC(2) to MC(n) are turned on (conducting). In addition, the corresponding switches SB(1) to SB(n) connecting the gate terminals of MC(2) to MC(n) and VS are turned off (not conducting). Switch SA(1) is controlled by logic circuits 35 such that when logic circuits 35 receive signal ANO from controller 30 and digital control signals DCS from digital registers 2, then logic circuits 35 actuate switch SA(1) (causes SA(1) to close) and stimulation current is delivered from output OUT(2) to its respective electrode. When logic circuits 35 de-activate switch SA(1) (causes SA(1) to open), current delivery from output OUT(2) is suspended.


Furthermore, at the same time, to ensure suspension of current delivery from output OUT(2), logic circuits 35 cause switch SB(1) to be activated. Stimulation therapy may be wirelessly controlled by an auxiliary device, such as a remote control or smart phone, to control the timing and duration of the activation of switches SA(1) and SB(1) so as to provide the desired current delivery in accordance with a predetermined therapy protocol. Preferably, logic circuits 35 control the states of switches SA(1) and SB(1) in a complementary fashion such that when switch SA(1) is activated, switch SB(1) is de-activated and vice versa.


Overall switching control can be accomplished by utilizing stimulation controller 30, digital registers 2 and logic circuits 35, either singly or in combination depending upon functional considerations.


In some embodiments, voltage VR1 is generated across resistor R1 when the current Isink flows from voltage source VS through resistor R1. In a like manner, voltage VR2 is generated across R2 when the overall stimulator output current IR2 flows through resistor R2 from voltage source VS. The voltage at the positive input of op amp 16 is the voltage sensed at the sources of transistors MC(1) to MC(n) when the corresponding switches SA(1) to SA(n) are activated and may be considered a common sensing voltage. Uniquely, and due to the feedback loop associated with op amp 16, the voltages at the positive and negative inputs of op amp 16 will be equal in steady state, and therefore, voltage VR2 is forced to be equal to VR1. At steady state, the current IR2 is equal to the sum of the output currents being delivered at all of the outputs OUT(2) to OUT(n). Accordingly, since VR2=IR2·R2 and VR1=Isink·R1, IR2 is equal to Isink·R1/R2 and the required overall current gain K defined as IR2/Isink, is therefore equal to R1/R2. Accordingly, setting the required overall current gain K is a matter of selecting the values of R1 and R2.


In some non-limiting applications, resistors may have better matched characteristics than MOSFETs in an integrated circuit as a function of area. For the same part to part matching accuracy, using resistors as described herein uses less area on an integrated circuit than using MOSFETs. An additional benefit in some instances may arise from the manner in which the resistors R1 and R2 may be constructed. For example, resistor R2 may be made from a number (Np) of parallel resistors and R1 may be made from a number (Ns) of series resistors. Accordingly, for a resistor value R, R1=R·Ns and R2=R/Np and the current gain K=R1/R2=Ns·Np. For the case when Ns=Np=N, the current gain K=N2 and with the total number of resistors equal to 2N (Ns+Np=2N), the total number of resistors as a function of current gain therefore is equal to 2·K1/2. For a current gain of 100, the number of resistors is 20, whereas a total of 101 individual transistors are required for M1 and M2 (See FIG. 1) since transistors cannot be connected in series for matching transistors connected in parallel. This may be more profound when considering current gains greater than the example K=100 where the saving in die area will be even greater. Still another advantage in some instances relates to the use of the disclosed current gain dependent resistor value technique because no calibration is typically required to achieve the required current gain accuracy and hence providing additional power and die area savings.


With reference to FIG. 4B, there is shown another embodiment of the current sensing multiple output current stimulator circuit 11B of the present invention. As discussed above, FIG. 4B includes only the anodic multiple output stimulator circuit and it is to be understood that a complementary circuit for cathodic stimulation although not shown in FIG. 4B is to be considered as optionally included in the overall circuit and system. Furthermore, it is to be understood that the invention also contemplates the use of a single multiple output stimulator whether it be for anodic or cathodic stimulation. Upon issuance of signal ANO from stimulation controller 30, current, designated as Isink flows through resistor R1 from voltage source VS and a voltage VR1 is generated across resistor R1 by virtue of the current Isink flowing through R1. Reference voltage VREF 14 is generated as a function of current Isink flowing through resistor R1 and is coupled to the negative input of operational amplifier (op amp) 16. Although the voltage VREF is coupled to the negative input of op amp 16, it is to be understood that reconfiguring the circuit connections to apply VREF to the positive input of op amp 16 is within the contemplation of the invention depending upon complementary circuit designs as may occur when using n channel MOSFET transistors in place of p channel transistors. The current Isink is coupled to reference current generator 6 shown in FIG. 3 via Isink PORT, as shown in FIG. 4B.


Circuit 11B further includes at least one pair of transistors coupled in a current mirror connection arrangement. More specifically, the gate of input side transistor ML(1) is coupled to the gate of output side transistor MC(1) and the commonly connected gate 32 is also connected to the drain of transistor ML(1). The source of transistor MC(1) is connected to voltage source VS through resistor R2 and the source of transistor ML(1) is connected to VS through resistor R3. The source of transistor MC(1) is also connected to the positive input of op amp 16 and provides a sensing voltage to op amp 16. The drain of transistor MC(1), designated as OUT(1), is coupled to a respective electrode (not shown) for delivery of stimulation current to the tissue in contact with such respective electrode.


The current mirror combination of transistors ML(1) and MC(1) is switchably coupled in a cascode arrangement to supply transistor MS through switch SA(1). More specifically, the drain of transistor ML(1) is coupled to one side of a “single pole single throw” switch SA(1) and the drain of transistor MS is coupled to the other side of switch SA(1). The source of transistor MS is coupled to voltage port 12, which for an anodic stimulator is ground and the gate of transistor MS is coupled to the output of op amp 16. For a cathodic stimulator, the voltage port is a voltage source such as VS. Switch SA(1) is controlled by logic circuits 35 such that when logic circuits 35 receive signal ANO from controller 30 and digital control signals DCS from digital registers 2, then logic circuits 35 actuate switch SA(1) (causes SA(1) to close) and stimulation current is delivered from output OUT(1) to its respective electrode. When logic circuits 35 de-activate switch SA(1) (causes SA(1) to open), current delivery from output OUT(1) is suspended.


Furthermore, at the same time, to ensure suspension of current delivery from output OUT(1), logic circuits 35 cause switch SB(1) to be activated. Stimulation therapy may be wirelessly controlled by an auxiliary device, such as a remote control or smart phone, to control the timing and duration of the activation of switches SA(1) and SB(1) so as to provide the desired current delivery in accordance with a predetermined therapy protocol. Preferably, logic circuits 35 control the states of switches SA(1) and SB(1) in a complementary fashion such that when switch SA(1) is activated, switch SB(1) is de-activated and vice versa.


Overall switching control can be accomplished by utilizing stimulation controller 30, digital registers 2 and logic circuits 35, either singly or in combination depending upon functional considerations.


Although the foregoing description relates to a single current mirror combination comprising transistors ML(1) and MC(1), multiple current mirror combinations are contemplated by the present invention. In this regard, FIG. 4B discloses transistor combinations comprising transistors ML(1) to ML(n) and MC(1) to MC(n), where n is the number of the individual current mirror combinations to supply stimulation current to n respective electrodes. As shown in FIG. 4B, each current mirror combination comprising ML(1) and MC(1) to ML(n) and MC(n) is coupled to supply transistor MS through a respective switch SA(1) to SA(n). The commonly connected source of each output side transistor MC(i) provides a common sensing voltage applied to the positive input of op amp 16. The output current delivered from any one output OUT(i) of a respective current mirror combination ML(i) and MC(i) to a respective electrode i, is controlled by digital registers 2 and logic circuits 35 by activating a respective switch SA(i) in accordance with a therapy or stimulation protocol. The protocol may instruct the stimulator to cause any output OUT(i) to provide stimulation current one at a time, or simultaneously in any combination or in any sequence and for any period of time.


As is taught in the prior art for current mirror configurations, input side transistors will exactly mirror the current supplied to it by a current source to the output side transistor only when the transistors are accurately matched (See for example, U.S. Pat. No. 8,575,971). Accordingly, in such cases transistor fabrication requirements place an undue burden on manufacturing and processing techniques resulting in lower device yields and higher device costs. Advantageously, some applications of the present invention obviate the necessity of strict manufacturing processes for establishing transistor width and length dimensions for establishing desired circuit current gain values. As will be discussed below, some embodiments of the present invention rely on selected circuit resistor values to dependably establish required current gain values. More specifically, resistors R1 and R2 in combination with op amp 16 control the gate voltage of supply transistor MS for achieving an accurate overall stimulator output current IR2 flowing through resistor R2. As is to be noted in FIG. 4B, the overall stimulator output current IR2 flowing through resistor R2 is the sum of the currents flowing to outputs OUT(1) through OUT(n) when the corresponding switches SA(1) to SA(n) are activated.


As further shown in FIG. 4B, the common gate connection (shown for example as 32 for ML(1) and MC(1)) of each current mirror coupled pair of transistors ML(i) and MC(i) is connected to voltage source VS through corresponding and respective switch SB(i). The state of the switches SB(1) to SB(n) is determined by logic circuits 35, such that when stimulation current is directed to a specific output OUT(i), the logic circuits 35 cause switch SA(i) to be activated and switch SB(i) to be de-activated, whereby current is delivered to OUT(i) through transistor MC(i). In a similar manner, when stimulation current is to be terminated from a specific output OUT(i), the logic circuits 35 cause switch SA(i) to be de-activated and switch SB(i) to be activated, whereby current delivery from OUT(i) is terminated (suspended).


Voltage VR1 is generated across resistor R1 when the current Isink flows from voltage source VS through resistor R1. In a like manner, voltage VR2 is generated across R2 when the overall stimulator output current IR2 flows through resistor R2 from voltage source VS. The voltage at the positive input of op amp 16 is the voltage sensed at the sources of transistors MC(1) to MC(n) when the corresponding switches SA(1) to SA(n) are activated and may be considered a common sensing voltage. Due to the feedback loop associated with op amp 16, the voltages at the positive and negative inputs of op amp 16 will be equal in steady state, and therefore, voltage VR2 is forced to be equal to VR1. At steady state, the current IR2 is equal to the sum of the output currents being delivered at all of the outputs OUT(1) to OUT(n). Accordingly, since VR2=IR2·R2 and VR1=Isink·R1, IR2 is equal to Isink·R1/R2 and the required overall current gain K defined as IR2/Isink, is therefore equal to R1/R2. Accordingly, setting the required overall current gain K is a matter of selecting the values of R1 and R2.


It is well known that resistors have better matched characteristics than MOSFETs in an integrated circuit for the same area. For the same part to part matching accuracy, using resistors in some applications of the present invention require less area on an integrated circuit than using MOSFETs. An additional benefit arising out of some applications of the present invention, relates to the manner in which the resistors R1 and R2 may be constructed. For example, resistor R2 may be made from a number (Np) of parallel resistors and R1 may be made from a number (Ns) of series resistors. Accordingly, for a resistor value R, R1=R·Ns and R2=R/Np and the current gain K=R1/R2=Ns·Np. For the case when Ns=Np=N, the current gain K=N2 and with the total number of resistors equal to 2N (Ns+Np=2N), the total number of required resistors as a function of current gain therefore is equal to 2·101/2. For a required current gain of 100, the number of required resistors is 20, whereas a total of 101 individual transistors are required for M1 and M2 (See FIG. 1) since transistors cannot be connected in series for matching transistors connected in parallel. This may be more profound when considering current gains greater than the example K=100 where the saving in die area will be even greater. Still another advantage of some applications of the present invention relates to the use of the disclosed current gain dependent resistor value technique because no calibration is typically required to achieve the required current gain accuracy and hence providing additional power and die area savings.


In practice, transistors ML(1) and MC(1) are set to have a width (W) to length (L) or W/L ratio of 1:L and the ratio of R3 to R2 is set to L:1. As a result the current IR3 flowing through resistor R3 and hence the current ID4 flowing through transistor MS is approximately equal to the current flowing through resistor R2 (IR2) divided by L or equivalently ID4=Isink·K/L at steady state as the op amp 16 forces VR2 to equal VR1. In this case, the current ID4 is well defined and substantially independent of process and temperature variations.


A further novel advantage of the implementation of op amp 16 in the stimulator circuit 11B in some applications is that during circuit activation, that is, when stimulation controller 30 issues the ANO signal which causes Isink to flow to thereby provide VREF and with IR2 equal to zero amps, the voltage difference between VR1 and VR2 is large such that the output voltage of op amp 16 is very large. It is to be noted however, that logic circuits 35, timed whether it be just prior to or concurrent with the providing of VREF, activate at least one or more preselected switches SA(i) corresponding to the outputs OUT(i) through which current is selected to be delivered. As a consequence, op amp 16 drives supply transistor MS to have a large initial gate to source voltage to thereby produce a large initial drain current ID4. In turn, the gate voltages of the selected transistors MC(i) corresponding to the selected switches SA(i), are drawn down quickly for turning these transistors on quickly. In other words, a large initial current ID4 occurs to discharge the large gate capacitances of selected transistors MC(i) quickly, resulting in a very short stimulator turn on time. The large initial current ID4 is designed to discharge all of the gate capacitances of the selected transistors MC(i).


This novel advantage may be very important in some applications, especially for short output current pulses in some instances. As illustrated in FIG. 5, when the stimulation controller 30 in FIG. 3 generates the signal ANO as shown in waveform 51 with the current Isink output as shown in waveform 52 into reference current generator 6, there will be a significant delay time TD1 as shown in waveform 53 from the rising edge Ton of ANO to one of the stimulator output currents Iout(i) for a stimulator, such as the stimulator of FIG. 2B, that does not have a short turn on time. Nevertheless, as shown in waveform 53, the turn off time for a typical stimulator is almost instantaneous after the falling edge Toff of ANO. As a result, the output current pulse produced by Iout(i) will be significantly shortened from the pulse width defined by the pulse width of ANO as illustrated in waveform 53 of FIG. 5. If the pulse width of ANO is shorter than TD1, Iout(i) will completely disappear. For a typical stimulator design with 8 outputs and a total current output of about 200 uA, TD1 will be over 100 us for a stimulator design based on FIG. 2A that utilizes high voltage transistors for realizing MC(1) to MC(n). In this case, it is assumed that the width-to-length ratio between M(1) and M(2) is 1:100 and the maximum output current of individual outputs (OUT(2) to OUT(n)) is over 25 mA. To support this maximum current at each output, high voltage transistors MC(2) to MC(n) are very large and have very large gate to source capacitances. For typical current stimulators, the shortest pulse is usually longer than 50 us.


Waveform 54 in FIG. 5 shows the benefit of the fast turn on characteristic of one non-limiting application of the present invention in that the time delay TD2 between Ton and the midpoint of the rising edge of current Iout(i) is very short, compared to the much longer time delay TD1 shown in waveform 53 of FIG. 5.


Although it is possible to compensate for the shortening of the current pulses by adjusting the pulse width of ANO to be TD1 longer than the desired pulse width, the delay time TD1 is often dependent on the amplitudes (or levels) of Iout(i) and/or the total output current IR2 into all the stimulation electrodes. Furthermore, there will be variations in TD1 between different stimulators implemented in different ICs due to process variations. Therefore, it is very difficult to correctly compensate for the delay time TD1 by adjusting the pulse width of ANO. In some embodiments, it may be advantageous to have a pulse generator that is capable of short turn on time over a range of output currents. In one embodiment, for example, the pulse generator may have turn on times less than 10 us, 5 us, 2 us, 1 us or any other or intermediate value and/or between, approximately 0.1 and 2 us, 0.1 and 4 us, 0.1 and 10 us, 0.1 and 20 us, 0.2 and 16 us, 0.3 and 12 us, 0.4 and 8 us, 0.5 and 6 us, 0.5 and 4 us, 0.5 and 2 us, 0.5 and 1 us, or any other or intermediate turn on time. In some embodiments, these turn on times can be achieved for output currents of less than 100 mA, 75 mA, 50 mA, 25 mA, or any other or intermediate current, and/or between 50 uA and 100 mA, 100 uA and 75 mA, 150 uA and 50 mA, 200 uA and 25 mA, 500 uA and 10 mA, or any other or intermediate current. In some embodiments, and as used above, approximately can comprise 10 percent of the defined range. FIG. 4B depicts on embodiment of a circuit 11B with a short turn on time. In FIG. 4B, circuit 11B has a turn on time in the range of 0.5-2 us for a total output current IR2 ranging between 200 uA and 25 mA for the number of working outputs being between 1 and 8. Even without any compensation of the pulse width of ANO, this short turn on time is quite tolerable even for the shortest pulse width of 50 us.


For the embodiment shown in FIG. 4B, the op amp frequency response is independent of the overall current IR2 and the number of outputs being turned on since the output of the op amp is only connected to the gate terminal of the supply transistor MS. Furthermore, due to the large initial current ID4 on the supply transistor as mentioned above, MC(1) to MC(n) are drawn down quickly for turning these transistors on quickly without using a high current driving capability op amp. Therefore, the turn on time of the present invention of FIG. 4B will be much shorter than that of the stimulator based on the circuit topology of FIG. 4A.


Circuit 11A, 11B can be used in a variety of stimulation devices. In one embodiment, the above mentioned advantages of circuit 11A, 11B enable use of circuit 11A, 11B in a peripherally-implantable neurostimulation system for treating neuropathic pain or for other uses.


Approximately 8% of the Western (EU and US) population is affected by Neuropathic pain (chronic intractable pain due to nerve damage). In about 5% of people, this pain is severe. There are at least 200,000 patients that have chronic intractable pain involving a nerve. Neuropathic pain can be very difficult to treat with only half of patients achieving partial relief. Thus, determining the best treatment for individual patients remains challenging. Conventional treatments include certain antidepressants, anti-epileptic drugs and opioids. However, side effects from these drugs can be detrimental. In some of these cases, electrical stimulation, including FES, can provide effect treatment of this pain without the drug-related side effects.


A spinal cord stimulator, which is one type of FES device, is a device used to deliver pulsed electrical signals to the spinal cord to control chronic pain. Because electrical stimulation is a purely electrical treatment and does not cause side effects similar to those caused by drugs, an increasing number of physicians and patients favor the use of electrical stimulation over drugs as a treatment for pain. The exact mechanisms of pain relief by spinal cord stimulation (SCS) are unknown. The scientific background of the SCS trials was based initially on the Gate Control Theory of pain that was first described by Melzack and Wall in 1965. The theory posits that pain is transmitted by two kinds of afferent nerve fibers. One is the larger myelinated Aδ fiber, which carries quick, intense-pain messages. The other is the smaller, unmyelinated “C” fiber, which transmits throbbing, chronic pain messages. A third type of nerve fiber, called AP, is “non-nociceptive,” meaning it does not transmit pain stimuli. The gate control theory asserts that signals transmitted by the Aδ and C pain fibers can be thwarted by the activation/stimulation of the non-nociceptie Aβ fibers and thus inhibit an individual's perception of pain. Thus, neurostimulation provides pain relief by blocking the pain messages before they reach the brain.


At the present time, SCS is used mostly in the treatment of failed back surgery syndrome, a complex regional pain syndrome that has refractory pain due to ischemia. SCS complications have been reported in 30% to 40% of all SCS patients. This increases the overall costs of patient pain management and decreases the efficacy of SCS. Common complications include: infection, hemorrhaging, injury of nerve tissue, placing device into the wrong compartment, hardware malfunction, lead migration, lead breakage, lead disconnection, lead erosion, pain at the implant site, generator overheating, and charger overheating. The occurrence rates of common complications are surprisingly high: 9.5% are accounted for lead extension connection issues, 6% are due to lead breakage, 22.6% of cases are associated with lead migration and 4.5% experienced infection.


Peripheral neuropathy may be either inherited or acquired. Causes of acquired peripheral neuropathy include physical injury (trauma) to a nerve, viruses, tumors, toxins, autoimmune responses, nutritional deficiencies, alcoholism, diabetes, and vascular and metabolic disorders. Acquired peripheral neuropathies are grouped into three broad categories: those caused by systemic disease, those caused by trauma, and those caused by infections or autoimmune disorders affecting nerve tissue. One example of an acquired peripheral neuropathy is trigeminal neuralgia, in which damage to the trigeminal nerve (the large nerve of the head and face) causes episodic attacks of excruciating, lightning-like pain on one side of the face.


A high percentage of patients with peripheral neuropathic pain do not benefit from SCS for various reasons. However, many of these patients can receive acceptable levels of pain relief via direct electrical stimulation to the corresponding peripheral nerves. This therapy is called peripheral nerve stimulation (PNS). There is, however, no FDA approved PNS devices in the US market. Standard spinal cord stimulator (SCS) devices are often used off label by pain physicians to treat this condition. It is estimated that about 15% of SCS devices have been used off-label for PNS.


As current commercially-available SCS systems were designed for stimulating the spinal cord and not for peripheral nerve stimulation, there are more device complications associated with the use of SCS systems for PNS than for SCS. Current SCS devices (generators) are large and bulky. In the event that an SCS is used for PNS, the SCS generator is typically implanted in the abdominal or in the lower back above the buttocks and long leads are tunneled across multiple joints to reach the target peripheral nerves in the arms, legs or face. The excessive tunneling and the crossing of joints leads to increased post-surgical pain and higher device failure rates. Additionally, rigid leads can lead to skin erosion and penetration, with lead failure rates nearing 100% within 3 years of implantation. Most complications result in replacement surgery and even multiple replacement surgeries in some cases.


One embodiment of a peripherally-implantable neurostimulation system 600 is shown in FIG. 6. In some embodiments, the peripherally-implantable neurostimulation system 600 can be used in treating patients with, for example, chronic, severe, refractory neuropathic pain originating from peripheral nerves. In some embodiments, the peripherally-implantable neurostimulation system 600 can be used to either stimulate a target peripheral nerve or the posterior epidural space of the spine.


The peripherally-implantable neurostimulation system 600 can include one or several pulse generators. The pulse generators can comprise a variety of shapes and sizes, and can be made from a variety of materials. In some embodiments, the one or several pulse generators can generate electrical pulses that are delivered to the nerve to control pain. In some embodiments, a pulse generator can be an external pulse generator 602 or an implantable pulse generator 604. In some embodiments, an external pulse generator 602 can be used to evaluate the suitability of a patient for treatment with the peripherally-implantable neurostimulation system 600 and/or for implantation of an implantable pulse generator 604.


The implantable pulse generator 604 can be sized and shaped, and made of material so as to allow implantation of the implantable pulse generator 604 inside of a body. In some embodiments, the implantable pulse generator 604 can be sized and shaped so as to allow placement of the implantable pulse generator 604 at any desired location in a body, and in some embodiments, placed proximate to peripheral nerve such that leads (discussed below) are not tunneled across joints and/or such that extension cables are not needed. In some embodiments, the pulse generator, and specifically the implantable pulse generator 604 and/or the external pulse generator 602 can incorporate one of the circuits 11A, 11B, as shown in either or both of the embodiments of FIGS. 4A and 4B.


In some embodiments, the electrical pulses generated by the pulse generator can be delivered to one or several nerves 610 and/or to tissue proximate to one or several nerves 610 via one or several leads. The leads can include conductive portions, referred to as electrodes, and non-conductive portions. The leads can have a variety of shapes, be a variety of sizes, and be made from a variety of materials, which size, shape, and materials can be dictated by the application or other factors.


In some embodiments, the leads can include an anodic lead 606 and/or a cathodic lead 608. In some embodiments, the anodic lead 606 and the cathodic lead 608 can be identical leads, but can receive pulses of different polarity from the pulse generator.


In some embodiments, the leads can connect directly to the pulse generator, and in some embodiments, the leads can be connected to the pulse generator via a connector 612 and a connector cable 614. The connector 612 can comprise any device that is able to electrically connect the leads to the connector cable 614. Likewise, the connector cable can be any device capable of transmitting distinct electrical pulses to the anodic lead 606 and the cathodic lead 608.


In some embodiments, the peripherally-implantable neurostimulation system 600 can include a charger 616 that can be configured to recharge the implantable pulse generator 604 when the implantable pulse generator 604 is implanted within a body. The charger 616 can comprise a variety of shapes, sizes, and features, and can be made from a variety of materials. In some embodiments, the charger 616 can recharge the implantable pulse generator 604 via an inductive coupling.


In some embodiments, details of the electrical pulses can be controlled via a controller. In some embodiments, these details can include, for example, the frequency, strength, pattern, duration, or other aspects of the timing and magnitude of the electrical pulses. This control of the electrical pulses can include the creation of one or several electrical pulse programs, plans, or patterns, and in some embodiments, this can include the selection of one or several pre-existing electrical pulse programs, plans, or patterns. In the embodiment depicted in FIG. 6, the peripherally-implantable neurostimulation system 600 includes a controller that is a clinician programmer 618. The clinician programmer 618 can be used to create one or several pulse programs, plans, or patterns and/or to select one or several of the created pulse programs, plans, or patterns. In some embodiments, the clinician programmer 618 can be used to program the operation of the pulse generators including, for example, one or both of the external pulse generator 602 and the implantable pulse generator 604. The clinician programmer 618 can comprise a computing device that can wiredly and/or wirelessly communicate with the pulse generators. In some embodiments, the clinician programmer 618 can be further configured to receive information from the pulse generators indicative of the operation and/or effectiveness of the pulse generators and the leads.


In some embodiments, the controller of the peripherally-implantable neurostimulation system 600 can include a patient remote 620. The patient remote 620 can comprise a computing device that can communicate with the pulse generators via a wired or wireless connection. The patient remote 620 can be used to program the pulse generator, and in some embodiments, the patient remote 620 can include one or several pulse generation programs, plans, or patterns created by the clinician programmer 618. In some embodiments, the patient remote 620 can be used to select one or several of the pre-existing pulse generation programs, plans, or patterns and to select, for example, the duration of the selected one of the one or several pulse generation programs, plans, or patterns.


Advantageously, the above outlined components of the peripherally-implantable neurostimulation system 600 can be used to control and provide the generation of electrical pulses to mitigate patient pain.


While the invention has been described by means of specific embodiments and applications thereof, it is understood that numerous modifications and variations could be made thereto by those skilled in the art without departing from the spirit and scope of the invention. It is therefore to be understood that within the scope of the claims, the invention may be practiced otherwise than as specifically described herein.

Claims
  • 1. An implantable neurostimulation system comprising: a pulse generator configured to generate one or several electrical pulses, the pulse generator comprising: a current generator configured to generate a reference current; anda stimulator comprising a stimulator circuit, wherein the stimulator circuit comprises: a plurality of output transistors, each of the output transistors comprising a gate;a supply transistor having an output connected to the gate of each of the plurality of output transistors; anda differential amplifier, wherein the output of the differential amplifier is arranged to drive the supply transistor;one or more leads connected to the pulse generator, the one or more leads comprising one or more electrodes, wherein the one or more leads are configured to conduct the one or several electrical pulses from the pulse generator to the one or more electrodes.
  • 2. The implantable neurostimulation system of claim 1, wherein the differential amplifier is arranged to drive the supply transistor as a function of a difference between a reference voltage and a common sensing voltage.
  • 3. The implantable neurostimulation system of claim 2, wherein the pulse generator further comprises a switching control circuit.
  • 4. The implantable neurostimulation system of claim 3, wherein the switching control circuit is configured to control a plurality of switches, each of the plurality of switches configured to selectively couple the output of the supply transistor to the gate of each of the plurality of output transistors.
  • 5. The implantable neurostimulation system of claim 4, wherein the switching control circuit is configured to control the reference voltage such that the reference voltage is provided upon activation of at least one switch in the plurality of switches to thereby discharge capacitances related to an output transistor corresponding to the at least one activated switch.
  • 6. The implantable neurostimulation system of claim 5, the differential amplifier is configured to drive the supply transistor so as to discharge capacitances related to the output transistor corresponding to the at least one activated switch upon the providing of the reference voltage.
  • 7. The implantable neurostimulation system of claim 1, wherein the stimulator circuit amplifies a reference current according to ratio of resistances of a first resistor and a second resistor.
  • 8. The implantable neurostimulation system of claim 1, wherein the stimulator circuit is configured to generate one or several electrical pulses.
  • 9. The implantable neurostimulation system of claim 1, further comprising a programmer configured to communicate with the pulse generator to create an electrical pulse program.
  • 10. The implantable neurostimulation system of claim 1, further comprising a remote configured to communicate with the pulse generator to select one of a plurality of electrical pulse programs stored on the pulse generator.
  • 11. The implantable neurostimulation system of claim 10, wherein the one of the plurality of pulse programs is configured to control operation of the pulse generator to generate the one or several electrical pulses.
  • 12. An implantable neurostimulation system comprising: a pulse generator configured to generate one or several electrical pulses, the pulse generator comprising: at least one input side transistor;a current generator configured to generate a reference current; anda stimulator comprising a stimulator circuit, wherein the stimulator circuit comprises a supply transistor having an output connected to one or several gates of one or several output transistors; andone or more leads connected to the pulse generator, the one or more leads comprising one or more electrodes, wherein the one or more leads are configured to conduct the one or several electrical pulses from the pulse generator to the one or more electrodes.
  • 13. The implantable neurostimulation system of claim 12, wherein each of the one or several-output transistors is paired with one of the at least one input side transistor.
  • 14. The implantable neurostimulation system of claim 12, wherein each of the one or several output transistors are current mirror coupled to at least one input side transistor, and wherein each of the one or several output transistors has a current output terminal for providing an output current.
  • 15. The implantable neurostimulation system of claim 14, wherein the supply transistor is switchably coupled in cascade arrangement between the at least one input side transistor and a voltage port.
  • 16. The implantable neurostimulation system of claim 15, wherein the voltage port is ground.
  • 17. The implantable neurostimulation system of claim 15, wherein the voltage port is a voltage source.
CROSS REFERENCE TO RELATED APPLICATION DATA

This application is a divisional of U.S. application Ser. No. 15/980,642 filed May 15, 2018, entitled “CURRENT SENSING MULTIPLE OUTPUT CURRENT STIMULATORS,” which is continuation of U.S. application Ser. No. 15/263,046 filed Sep. 12, 2016, entitled “CURRENT SENSING MULTIPLE OUTPUT CURRENT STIMULATORS,” and issued as U.S. Pat. No. 9,981,130 on May 29, 2018, which is a divisional of U.S. application Ser. No. 14/217,321 filed Mar. 17, 2014, entitled “CURRENT SENSING MULTIPLE OUTPUT CURRENT STIMULATORS;” and issued as U.S. Pat. No. 9,446,241 on Sep. 20, 2016, which claims the benefit of U.S. Provisional Application No. 61/788,871 filed Mar. 15, 2013; the entirety of each which is hereby incorporated by reference herein.

US Referenced Citations (603)
Number Name Date Kind
3057356 Greatbatch Oct 1962 A
3348548 Chardack Oct 1967 A
3646940 Timm et al. Mar 1972 A
3824129 Fagan, Jr. Jul 1974 A
3825015 Berkovits Jul 1974 A
3888260 Fischell Jun 1975 A
3902501 Citron et al. Sep 1975 A
3939843 Smyth Feb 1976 A
3942535 Schulman Mar 1976 A
3970912 Hoffman Jul 1976 A
3995623 Blake et al. Dec 1976 A
4019518 Maurer et al. Apr 1977 A
4044774 Corbin et al. Aug 1977 A
4082097 Mann et al. Apr 1978 A
4141365 Fischell et al. Feb 1979 A
4166469 Littleford Sep 1979 A
4269198 Stokes May 1981 A
4285347 Hess Aug 1981 A
4340062 Thompson et al. Jul 1982 A
4379462 Borkan et al. Apr 1983 A
4407303 Akerstrom Oct 1983 A
4437475 White Mar 1984 A
4468723 Hughes Aug 1984 A
4512351 Pohndorf Apr 1985 A
4550731 Batina et al. Nov 1985 A
4558702 Barreras et al. Dec 1985 A
4654880 Sontag Mar 1987 A
4662382 Sluetz et al. May 1987 A
4673867 Davis Jun 1987 A
4719919 Marchosky et al. Jan 1988 A
4721118 Harris Jan 1988 A
4722353 Sluetz Feb 1988 A
4744371 Harris May 1988 A
4800898 Hess et al. Jan 1989 A
4848352 Pohndorf et al. Jul 1989 A
4860446 Lessar et al. Aug 1989 A
4957118 Erlebacher Sep 1990 A
4989617 Memberg et al. Feb 1991 A
5012176 Laforge Apr 1991 A
5052407 Hauser et al. Oct 1991 A
5143089 Alt Sep 1992 A
5193539 Schulman et al. Mar 1993 A
5197466 Marchosky et al. Mar 1993 A
5204611 Nor et al. Apr 1993 A
5255691 Otten Oct 1993 A
5257634 Kroll Nov 1993 A
5342408 Decoriolis et al. Aug 1994 A
5439485 Mar et al. Aug 1995 A
5476499 Hirschberg Dec 1995 A
5484445 Knuth Jan 1996 A
5571148 Loeb et al. Nov 1996 A
5592070 Mino Jan 1997 A
5637981 Nagai et al. Jun 1997 A
5676162 Larson, Jr. et al. Oct 1997 A
5690693 Wang et al. Nov 1997 A
5702428 Tippey et al. Dec 1997 A
5702431 Wang et al. Dec 1997 A
5712795 Layman et al. Jan 1998 A
5713939 Nedungadi et al. Feb 1998 A
5733313 Barreras, Sr. et al. Mar 1998 A
5735887 Barreras, Sr. et al. Apr 1998 A
5741316 Chen et al. Apr 1998 A
5871532 Schroeppel Feb 1999 A
5876423 Braun Mar 1999 A
5877472 Campbell et al. Mar 1999 A
5902331 Bonner et al. May 1999 A
5948006 Mann Sep 1999 A
5949632 Barreras, Sr. et al. Sep 1999 A
5957965 Moumane et al. Sep 1999 A
5991665 Wang et al. Nov 1999 A
6027456 Feler et al. Feb 2000 A
6035237 Schulman et al. Mar 2000 A
6055456 Gerber Apr 2000 A
6057513 Ushikoshi et al. May 2000 A
6067474 Schulman et al. May 2000 A
6075339 Reipur et al. Jun 2000 A
6076017 Taylor et al. Jun 2000 A
6081097 Seri et al. Jun 2000 A
6083247 Rutten et al. Jul 2000 A
6104957 Alo et al. Aug 2000 A
6104960 Duysens et al. Aug 2000 A
6138681 Chen et al. Oct 2000 A
6164284 Schulman et al. Dec 2000 A
6165180 Cigaina et al. Dec 2000 A
6166518 Echarri et al. Dec 2000 A
6169387 Kaib Jan 2001 B1
6172556 Prentice Jan 2001 B1
6178353 Griffith et al. Jan 2001 B1
6181105 Cutolo et al. Jan 2001 B1
6185452 Schulman et al. Feb 2001 B1
6191365 Avellanet Feb 2001 B1
6208894 Schulman et al. Mar 2001 B1
6212430 Kung Apr 2001 B1
6212431 Hahn et al. Apr 2001 B1
6221513 Lasater Apr 2001 B1
6227204 Baumann et al. May 2001 B1
6243608 Pauly et al. Jun 2001 B1
6246911 Seligman Jun 2001 B1
6249703 Stanton et al. Jun 2001 B1
6265789 Honda et al. Jul 2001 B1
6275737 Mann Aug 2001 B1
6278258 Echarri et al. Aug 2001 B1
6305381 Weijand et al. Oct 2001 B1
6306100 Prass Oct 2001 B1
6313779 Leung et al. Nov 2001 B1
6315721 Schulman et al. Nov 2001 B2
6316909 Honda et al. Nov 2001 B1
6321118 Hahn Nov 2001 B1
6327504 Dolgin et al. Dec 2001 B1
6354991 Gross et al. Mar 2002 B1
6360750 Gerber et al. Mar 2002 B1
6381496 Meadows et al. Apr 2002 B1
6393325 Mann et al. May 2002 B1
6427086 Fischell et al. Jul 2002 B1
6438423 Rezai et al. Aug 2002 B1
6442434 Zarinetchi et al. Aug 2002 B1
6453198 Torgerson et al. Sep 2002 B1
6466817 Kaula et al. Oct 2002 B1
6473652 Sarwal et al. Oct 2002 B1
6500141 Irion Dec 2002 B1
6505075 Weiner Jan 2003 B1
6505077 Kast et al. Jan 2003 B1
6510347 Borkan Jan 2003 B2
6516227 Meadows et al. Feb 2003 B1
6517227 Stidham et al. Feb 2003 B2
6521350 Fey et al. Feb 2003 B2
6542846 Miller et al. Apr 2003 B1
6553263 Meadows et al. Apr 2003 B1
6564807 Schulman et al. May 2003 B1
6584355 Stessman Jun 2003 B2
6600954 Cohen et al. Jul 2003 B2
6609031 Law et al. Aug 2003 B1
6609032 Woods et al. Aug 2003 B1
6609945 Jimenez et al. Aug 2003 B2
6652449 Gross et al. Nov 2003 B1
6662051 Eraker et al. Dec 2003 B1
6664763 Echarri et al. Dec 2003 B2
6685638 Taylor et al. Feb 2004 B1
6721603 Zabara et al. Apr 2004 B2
6735474 Loeb et al. May 2004 B1
6745077 Griffith et al. Jun 2004 B1
6809701 Amundson et al. Oct 2004 B2
6836684 Rijkhoff et al. Dec 2004 B1
6847849 Mamo et al. Jan 2005 B2
6864755 Moore Mar 2005 B2
6892098 Ayal et al. May 2005 B2
6895280 Meadows et al. May 2005 B2
6896651 Gross et al. May 2005 B2
6901287 Davis et al. May 2005 B2
6941171 Mann et al. Sep 2005 B2
6971393 Mamo et al. Dec 2005 B1
6986453 Jiang et al. Jan 2006 B2
6989200 Byers et al. Jan 2006 B2
6990376 Tanagho et al. Jan 2006 B2
6999819 Swoyer et al. Feb 2006 B2
7051419 Schrom et al. May 2006 B2
7054689 Whitehurst et al. May 2006 B1
7069081 Biggs et al. Jun 2006 B2
7114502 Schulman et al. Oct 2006 B2
7127298 He et al. Oct 2006 B1
7131996 Wasserman et al. Nov 2006 B2
7142925 Bhadra et al. Nov 2006 B1
7146219 Sieracki et al. Dec 2006 B2
7151914 Brewer Dec 2006 B2
7167749 Biggs et al. Jan 2007 B2
7167756 Torgerson et al. Jan 2007 B1
7177690 Woods et al. Feb 2007 B2
7177698 Klosterman et al. Feb 2007 B2
7181286 Sieracki et al. Feb 2007 B2
7184836 Meadows et al. Feb 2007 B1
7187978 Malek et al. Mar 2007 B2
7191005 Stessman Mar 2007 B2
7212110 Martin et al. May 2007 B1
7225028 Della Santina et al. May 2007 B2
7225032 Schmeling et al. May 2007 B2
7231254 DiLorenzo Jun 2007 B2
7234853 Givoletti Jun 2007 B2
7239918 Strother et al. Jul 2007 B2
7245972 Davis Jul 2007 B2
7286880 Olson et al. Oct 2007 B2
7295878 Meadows et al. Nov 2007 B1
7305268 Gliner et al. Dec 2007 B2
7317948 King et al. Jan 2008 B1
7324852 Barolat et al. Jan 2008 B2
7324853 Ayal et al. Jan 2008 B2
7328068 Spinelli et al. Feb 2008 B2
7330764 Swoyer et al. Feb 2008 B2
7331499 Jiang et al. Feb 2008 B2
7359751 Erickson et al. Apr 2008 B1
7369894 Gerber May 2008 B2
7386348 North et al. Jun 2008 B2
7387603 Gross et al. Jun 2008 B2
7396265 Darley et al. Jul 2008 B2
7415308 Gerber et al. Aug 2008 B2
7444181 Shi et al. Oct 2008 B2
7444184 Boveja et al. Oct 2008 B2
7450991 Smith et al. Nov 2008 B2
7460911 Cosendai et al. Dec 2008 B2
7463928 Lee et al. Dec 2008 B2
7470236 Kelleher et al. Dec 2008 B1
7483752 Von Arx et al. Jan 2009 B2
7486048 Tsukamoto et al. Feb 2009 B2
7496404 Meadows et al. Feb 2009 B2
7513257 Schulman et al. Apr 2009 B2
7515967 Phillips et al. Apr 2009 B2
7532936 Erickson et al. May 2009 B2
7539538 Parramon et al. May 2009 B2
7551960 Forsberg et al. Jun 2009 B2
7555346 Woods et al. Jun 2009 B1
7565203 Greenberg et al. Jul 2009 B2
7578819 Bleich et al. Aug 2009 B2
7580752 Gerber et al. Aug 2009 B2
7582053 Gross et al. Sep 2009 B2
7617002 Goetz Nov 2009 B2
7636602 Baru Fassio et al. Dec 2009 B2
7640059 Forsberg et al. Dec 2009 B2
7643880 Tanagho et al. Jan 2010 B2
7650192 Wahlstrand Jan 2010 B2
7706889 Gerber et al. Apr 2010 B2
7720547 Denker et al. May 2010 B2
7725191 Greenberg et al. May 2010 B2
7734355 Cohen et al. Jun 2010 B2
7738963 Hickman et al. Jun 2010 B2
7738965 Phillips et al. Jun 2010 B2
7747330 Nolan et al. Jun 2010 B2
7771838 He et al. Aug 2010 B1
7774069 Olson et al. Aug 2010 B2
7801619 Gerber et al. Sep 2010 B2
7813803 Heruth et al. Oct 2010 B2
7813809 Strother et al. Oct 2010 B2
7826901 Lee et al. Nov 2010 B2
7848818 Barolat et al. Dec 2010 B2
7878207 Goetz et al. Feb 2011 B2
7904167 Klosterman et al. Mar 2011 B2
7912555 Swoyer et al. Mar 2011 B2
7925357 Phillips et al. Apr 2011 B2
7932696 Peterson Apr 2011 B2
7933656 Sieracki et al. Apr 2011 B2
7935051 Miles et al. May 2011 B2
7937158 Erickson et al. May 2011 B2
7952349 Huang et al. May 2011 B2
7957818 Swoyer Jun 2011 B2
7979119 Kothandaraman et al. Jul 2011 B2
7979126 Payne et al. Jul 2011 B2
7988507 Darley et al. Aug 2011 B2
8000782 Gharib et al. Aug 2011 B2
8000800 Takeda et al. Aug 2011 B2
8000805 Swoyer et al. Aug 2011 B2
8005535 Gharib et al. Aug 2011 B2
8005549 Boser et al. Aug 2011 B2
8005550 Boser et al. Aug 2011 B2
8019423 Possover Sep 2011 B2
8024047 Olson et al. Sep 2011 B2
8036756 Swoyer et al. Oct 2011 B2
8044635 Peterson Oct 2011 B2
8050769 Gharib et al. Nov 2011 B2
8055337 Moffitt et al. Nov 2011 B2
8068912 Kaula et al. Nov 2011 B2
8083663 Gross et al. Dec 2011 B2
8103360 Foster Jan 2012 B2
8116862 Stevenson et al. Feb 2012 B2
8121701 Woods et al. Feb 2012 B2
8129942 Park et al. Mar 2012 B2
8131358 Moffitt et al. Mar 2012 B2
8140168 Olson et al. Mar 2012 B2
8145324 Stevenson et al. Mar 2012 B1
8150530 Wesselink Apr 2012 B2
8175717 Haller et al. May 2012 B2
8180451 Hickman et al. May 2012 B2
8180452 Shaquer May 2012 B2
8180461 Mamo et al. May 2012 B2
8214042 Ozawa et al. Jul 2012 B2
8214048 Whitehurst et al. Jul 2012 B1
8214051 Sieracki et al. Jul 2012 B2
8219196 Torgerson Jul 2012 B2
8219202 Giftakis et al. Jul 2012 B2
8224460 Schleicher et al. Jul 2012 B2
8233990 Goetz Jul 2012 B2
8255057 Fang et al. Aug 2012 B2
8311636 Gerber et al. Nov 2012 B2
8314594 Scott et al. Nov 2012 B2
8332040 Winstrom Dec 2012 B1
8340786 Gross et al. Dec 2012 B2
8362742 Kallmyer Jan 2013 B2
8369943 Shuros et al. Feb 2013 B2
8386048 McClure et al. Feb 2013 B2
8417346 Giftakis et al. Apr 2013 B2
8423146 Giftakis et al. Apr 2013 B2
8447402 Jiang et al. May 2013 B1
8447408 North et al. May 2013 B2
8457756 Rahman Jun 2013 B2
8457758 Olson et al. Jun 2013 B2
8467875 Bennett et al. Jun 2013 B2
8480437 Dilmaghanian et al. Jul 2013 B2
8494625 Hargrove Jul 2013 B2
8515545 Trier Aug 2013 B2
8538530 Orinski Sep 2013 B1
8543223 Sage et al. Sep 2013 B2
8544322 Minami et al. Oct 2013 B2
8549015 Barolat Oct 2013 B2
8554322 Olson et al. Oct 2013 B2
8555894 Schulman et al. Oct 2013 B2
8562539 Marino Oct 2013 B2
8571677 Torgerson et al. Oct 2013 B2
8577474 Rahman et al. Nov 2013 B2
8588917 Whitehurst et al. Nov 2013 B2
8612002 Faltys et al. Dec 2013 B2
8620436 Parramon et al. Dec 2013 B2
8626314 Swoyer et al. Jan 2014 B2
8644933 Ozawa et al. Feb 2014 B2
8655451 Klosterman et al. Feb 2014 B2
8700175 Fell Apr 2014 B2
8706254 Vamos et al. Apr 2014 B2
8725262 Olson et al. May 2014 B2
8725269 Nolan et al. May 2014 B2
8738141 Smith et al. May 2014 B2
8738148 Olson et al. May 2014 B2
8750985 Parramon et al. Jun 2014 B2
8761897 Kaula et al. Jun 2014 B2
8768452 Gerber Jul 2014 B2
8774912 Gerber Jul 2014 B2
8855767 Faltys et al. Oct 2014 B2
8918174 Woods et al. Dec 2014 B2
8954148 Labbe et al. Feb 2015 B2
8989861 Su et al. Mar 2015 B2
9044592 Imran et al. Jun 2015 B2
9050473 Woods et al. Jun 2015 B2
9089712 Joshi et al. Jul 2015 B2
9108063 Olson et al. Aug 2015 B2
9144680 Kaula et al. Sep 2015 B2
9149635 Denison et al. Oct 2015 B2
9155885 Wei et al. Oct 2015 B2
9166321 Smith et al. Oct 2015 B2
9168374 Su Oct 2015 B2
9192763 Gerber et al. Nov 2015 B2
9197173 Denison et al. Nov 2015 B2
9199075 Westlund Dec 2015 B1
9205255 Strother et al. Dec 2015 B2
9209634 Cottrill et al. Dec 2015 B2
9216294 Bennett et al. Dec 2015 B2
9227055 Wahlstrand et al. Jan 2016 B2
9227076 Sharma et al. Jan 2016 B2
9238135 Goetz et al. Jan 2016 B2
9240630 Joshi Jan 2016 B2
9242090 Atalar et al. Jan 2016 B2
9244898 Vamos et al. Jan 2016 B2
9248292 Trier et al. Feb 2016 B2
9259578 Torgerson et al. Feb 2016 B2
9259582 Joshi et al. Feb 2016 B2
9265958 Joshi et al. Feb 2016 B2
9270134 Gaddam et al. Feb 2016 B2
9272140 Gerber et al. Mar 2016 B2
9283394 Whitehurst et al. Mar 2016 B2
9295851 Gordon et al. Mar 2016 B2
9308022 Chitre et al. Apr 2016 B2
9308382 Strother et al. Apr 2016 B2
9314616 Wells et al. Apr 2016 B2
9320899 Parramon et al. Apr 2016 B2
9333339 Weiner May 2016 B2
9352148 Stevenson et al. May 2016 B2
9352150 Stevenson et al. May 2016 B2
9358039 Kimmel et al. Jun 2016 B2
9364658 Wechter Jun 2016 B2
9375574 Kaula et al. Jun 2016 B2
9393423 Parramon et al. Jul 2016 B2
9399137 Parker et al. Jul 2016 B2
9409020 Parker Aug 2016 B2
9415211 Bradley et al. Aug 2016 B2
9427571 Sage et al. Aug 2016 B2
9427573 Gindele et al. Aug 2016 B2
9433783 Wei et al. Sep 2016 B2
9436481 Drew Sep 2016 B2
9446241 Lee Sep 2016 B2
9446245 Grill et al. Sep 2016 B2
9463324 Olson et al. Oct 2016 B2
9468755 Westlund et al. Oct 2016 B2
9471753 Kaula et al. Oct 2016 B2
9480846 Strother et al. Nov 2016 B2
9492672 Vamos et al. Nov 2016 B2
9492675 Torgerson et al. Nov 2016 B2
9492678 Chow Nov 2016 B2
9498628 Kaemmerer et al. Nov 2016 B2
9502754 Zhao et al. Nov 2016 B2
9504830 Kaula et al. Nov 2016 B2
9522282 Chow et al. Dec 2016 B2
9592389 Moffitt Mar 2017 B2
9610449 Kaula et al. Apr 2017 B2
9615744 Denison et al. Apr 2017 B2
9623257 Olson et al. Apr 2017 B2
9636497 Bradley et al. May 2017 B2
9643004 Gerber May 2017 B2
9653935 Cong et al. May 2017 B2
9656074 Simon et al. May 2017 B2
9656076 Trier et al. May 2017 B2
9656089 Yip et al. May 2017 B2
9675809 Chow Jun 2017 B2
9687649 Thacker Jun 2017 B2
9707405 Shishilla et al. Jul 2017 B2
9713706 Gerber Jul 2017 B2
9717900 Swoyer et al. Aug 2017 B2
9724526 Strother et al. Aug 2017 B2
9731116 Chen Aug 2017 B2
9737704 Wahlstrand et al. Aug 2017 B2
9744347 Chen et al. Aug 2017 B2
9750930 Chen Sep 2017 B2
9757555 Novotny et al. Sep 2017 B2
9764147 Torgerson Sep 2017 B2
9767255 Kaula et al. Sep 2017 B2
9776002 Parker et al. Oct 2017 B2
9776006 Parker et al. Oct 2017 B2
9776007 Kaula et al. Oct 2017 B2
9782596 Vamos et al. Oct 2017 B2
9814884 Parker et al. Nov 2017 B2
9821112 Olson et al. Nov 2017 B2
9827415 Stevenson et al. Nov 2017 B2
9827424 Kaula et al. Nov 2017 B2
9833614 Gliner Dec 2017 B1
9849278 Spinelli et al. Dec 2017 B2
9855438 Parramon et al. Jan 2018 B2
9872988 Kaula et al. Jan 2018 B2
9878165 Wilder et al. Jan 2018 B2
9878168 Shishilla et al. Jan 2018 B2
9882420 Cong et al. Jan 2018 B2
9884198 Parker Feb 2018 B2
9889292 Gindele et al. Feb 2018 B2
9889293 Siegel et al. Feb 2018 B2
9889306 Stevenson et al. Feb 2018 B2
9895532 Kaula et al. Feb 2018 B2
9899778 Hanson et al. Feb 2018 B2
9901284 Olsen et al. Feb 2018 B2
9901740 Drees et al. Feb 2018 B2
9907476 Bonde et al. Mar 2018 B2
9907955 Bakker et al. Mar 2018 B2
9907957 Woods et al. Mar 2018 B2
9924904 Cong et al. Mar 2018 B2
9931513 Kelsch et al. Apr 2018 B2
9931514 Frysz et al. Apr 2018 B2
9950171 Johanek et al. Apr 2018 B2
9974108 Polefko May 2018 B2
9974949 Thompson et al. May 2018 B2
9981121 Seifert et al. May 2018 B2
9981130 Lee May 2018 B2
9981137 Eiger May 2018 B2
9987493 Torgerson et al. Jun 2018 B2
9993650 Seitz et al. Jun 2018 B2
9999765 Stevenson Jun 2018 B2
10004910 Gadagkar et al. Jun 2018 B2
10016596 Stevenson et al. Jul 2018 B2
10027157 Labbe et al. Jul 2018 B2
10045764 Scott et al. Aug 2018 B2
10046164 Gerber Aug 2018 B2
10047782 Sage et al. Aug 2018 B2
10052490 Kaula et al. Aug 2018 B2
10065044 Sharma et al. Sep 2018 B2
10071247 Childs Sep 2018 B2
10076661 Wei et al. Sep 2018 B2
10076667 Kaula et al. Sep 2018 B2
10083261 Kaula et al. Sep 2018 B2
10086191 Bonde et al. Oct 2018 B2
10086203 Kaemmerer Oct 2018 B2
10092747 Sharma et al. Oct 2018 B2
10092749 Stevenson et al. Oct 2018 B2
10095837 Corey et al. Oct 2018 B2
10099051 Stevenson et al. Oct 2018 B2
10103559 Cottrill et al. Oct 2018 B2
10109844 Dai et al. Oct 2018 B2
10118037 Kaula et al. Nov 2018 B2
10124164 Stevenson et al. Nov 2018 B2
10124171 Kaula et al. Nov 2018 B2
10124179 Norton et al. Nov 2018 B2
10141545 Kraft et al. Nov 2018 B2
10173062 Parker Jan 2019 B2
10179241 Walker et al. Jan 2019 B2
10179244 Lebaron et al. Jan 2019 B2
10183162 Johnson et al. Jan 2019 B2
10188857 North et al. Jan 2019 B2
10195419 Shiroff et al. Feb 2019 B2
10206710 Kern et al. Feb 2019 B2
10213229 Chitre et al. Feb 2019 B2
10220210 Walker et al. Mar 2019 B2
10226617 Finley et al. Mar 2019 B2
10226636 Gaddam et al. Mar 2019 B2
10236709 Decker et al. Mar 2019 B2
10238863 Gross et al. Mar 2019 B2
10238877 Kaula et al. Mar 2019 B2
10244956 Kane Apr 2019 B2
10245434 Kaula et al. Apr 2019 B2
10258800 Perryman et al. Apr 2019 B2
10265532 Carcieri et al. Apr 2019 B2
10277055 Peterson et al. Apr 2019 B2
10293168 Bennett et al. May 2019 B2
10328253 Wells Jun 2019 B2
10363419 Simon et al. Jul 2019 B2
10369275 Olson et al. Aug 2019 B2
10369370 Shishilla et al. Aug 2019 B2
10376701 Kaula et al. Aug 2019 B2
10448889 Gerber et al. Oct 2019 B2
10456574 Chen et al. Oct 2019 B2
10471262 Perryman et al. Nov 2019 B2
10485970 Gerber et al. Nov 2019 B2
10493282 Caparso et al. Dec 2019 B2
10493287 Yoder et al. Dec 2019 B2
10561835 Gerber Feb 2020 B2
10603495 Lee Mar 2020 B2
20020040185 Atalar et al. Apr 2002 A1
20020051550 Leysieffer May 2002 A1
20020051551 Leysieffer et al. May 2002 A1
20020116042 Boling Aug 2002 A1
20020140399 Echarri et al. Oct 2002 A1
20020177884 Ahn et al. Nov 2002 A1
20030028072 Fischell et al. Feb 2003 A1
20030078633 Firlik et al. Apr 2003 A1
20030114899 Woods et al. Jun 2003 A1
20030212440 Boveja Nov 2003 A1
20040098068 Carbunaru et al. May 2004 A1
20040106963 Tsukamoto et al. Jun 2004 A1
20040210290 Omar-Pasha Oct 2004 A1
20040250820 Forsell Dec 2004 A1
20040267137 Peszynski et al. Dec 2004 A1
20050004619 Wahlstrand et al. Jan 2005 A1
20050004621 Boveja et al. Jan 2005 A1
20050021108 Klosterman et al. Jan 2005 A1
20050075693 Toy et al. Apr 2005 A1
20050075694 Schmeling et al. Apr 2005 A1
20050075696 Forsberg et al. Apr 2005 A1
20050075697 Olson et al. Apr 2005 A1
20050075698 Phillips et al. Apr 2005 A1
20050075699 Olson et al. Apr 2005 A1
20050075700 Schommer et al. Apr 2005 A1
20050104577 Matei et al. May 2005 A1
20050187590 Boveja et al. Aug 2005 A1
20050240242 DiLorenzo Oct 2005 A1
20050267546 Parramon Dec 2005 A1
20060016452 Goetz et al. Jan 2006 A1
20060050539 Yang et al. Mar 2006 A1
20060142822 Tulgar Jun 2006 A1
20060149345 Boggs et al. Jul 2006 A1
20060200205 Haller Sep 2006 A1
20060206166 Weiner Sep 2006 A1
20070032836 Thrope et al. Feb 2007 A1
20070073357 Rooney et al. Mar 2007 A1
20070239224 Bennett et al. Oct 2007 A1
20070265675 Lund et al. Nov 2007 A1
20070293914 Woods et al. Dec 2007 A1
20080065182 Strother et al. Mar 2008 A1
20080132961 Jaax et al. Jun 2008 A1
20080132969 Bennett et al. Jun 2008 A1
20080154335 Thrope et al. Jun 2008 A1
20080161874 Bennett et al. Jul 2008 A1
20080172109 Rahman et al. Jul 2008 A1
20080183236 Gerber Jul 2008 A1
20080278974 Wu Nov 2008 A1
20090088816 Harel et al. Apr 2009 A1
20090105785 Wei et al. Apr 2009 A1
20090112291 Wahlstrand et al. Apr 2009 A1
20090259273 Figueiredo et al. Oct 2009 A1
20100076254 Jimenez et al. Mar 2010 A1
20100076534 Mock Mar 2010 A1
20100100158 Thrope et al. Apr 2010 A1
20110152959 Sherwood et al. Jun 2011 A1
20110257701 Strother et al. Oct 2011 A1
20110270269 Swoyer et al. Nov 2011 A1
20110276103 Maile et al. Nov 2011 A1
20110278948 Forsell Nov 2011 A1
20110282416 Hamann et al. Nov 2011 A1
20110301667 Olson et al. Dec 2011 A1
20120016447 Zhu et al. Jan 2012 A1
20120041512 Weiner Feb 2012 A1
20120046712 Woods et al. Feb 2012 A1
20120071950 Archer Mar 2012 A1
20120119698 Karalis et al. May 2012 A1
20120130448 Woods et al. May 2012 A1
20120259381 Smith et al. Oct 2012 A1
20120262108 Olson et al. Oct 2012 A1
20120274270 Dinsmoor et al. Nov 2012 A1
20120276854 Joshi et al. Nov 2012 A1
20120276856 Joshi et al. Nov 2012 A1
20130004925 Labbe et al. Jan 2013 A1
20130006330 Wilder et al. Jan 2013 A1
20130006331 Weisgarber et al. Jan 2013 A1
20130023958 Fell Jan 2013 A1
20130096651 Ozawa et al. Apr 2013 A1
20130148768 Kim Jun 2013 A1
20130150925 Vamos et al. Jun 2013 A1
20130197608 Eiger Aug 2013 A1
20130207863 Joshi Aug 2013 A1
20130211479 Olson et al. Aug 2013 A1
20130303942 Damaser et al. Nov 2013 A1
20130310894 Trier Nov 2013 A1
20130331909 Gerber Dec 2013 A1
20140222112 Fell Aug 2014 A1
20140237806 Smith et al. Aug 2014 A1
20140277270 Parramon et al. Sep 2014 A1
20150088227 Shishilla et al. Mar 2015 A1
20150123608 Dearden et al. May 2015 A1
20150214604 Zhao et al. Jul 2015 A1
20170197079 Illegems et al. Jul 2017 A1
20170340878 Wahlstrand et al. Nov 2017 A1
20180021587 Strother et al. Jan 2018 A1
20180036477 Olson et al. Feb 2018 A1
20190269918 Parker Sep 2019 A1
20190351244 Shishilla et al. Nov 2019 A1
20190358395 Olson et al. Nov 2019 A1
Foreign Referenced Citations (43)
Number Date Country
520440 Sep 2011 AT
4664800 Nov 2000 AU
5123800 Nov 2000 AU
2014232252 May 2018 AU
2371378 Nov 2000 CA
2554676 Sep 2005 CA
1956750 May 2007 CN
105164920 Feb 2018 CN
3146182 Jun 1983 DE
102010006837 Aug 2011 DE
0656218 Jun 1995 EP
1205004 May 2002 EP
1680182 Jul 2006 EP
1904153 Apr 2008 EP
2243509 Oct 2010 EP
2395128 Feb 2013 ES
1098715 Mar 2012 HK
2003047179 Feb 2003 JP
2007268293 Oct 2007 JP
4125357 Jul 2008 JP
6298145 Mar 2018 JP
9820933 May 1998 WO
9918879 Apr 1999 WO
9934870 Jul 1999 WO
9942173 Aug 1999 WO
0056677 Sep 2000 WO
0065682 Nov 2000 WO
0066221 Nov 2000 WO
0069012 Nov 2000 WO
0183029 Nov 2001 WO
0203408 Jan 2002 WO
0209808 Feb 2002 WO
2004021876 Mar 2004 WO
2004103465 Dec 2004 WO
2005079295 Sep 2005 WO
2005081740 Sep 2005 WO
2008021524 Feb 2008 WO
2009051539 Apr 2009 WO
2009091267 Jul 2009 WO
2010042056 Apr 2010 WO
2010042057 Apr 2010 WO
2011059565 May 2011 WO
2013141884 Sep 2013 WO
Non-Patent Literature Citations (49)
Entry
US 9,601,939 B2, 03/2017, Cong et al. (withdrawn)
Bu-802a: How Does Rising Internal Resistance Affect Performance? Understanding the Importance of Low Conductivity, BatteryUniversity.com, Available Online at https://batteryuniversity.com/learn/article/rising_internal_resistance, Accessed from Internet on: May 15, 2020, 10 pages.
DOE Handbook: Primer on Lead-Acid Storage Batteries, U.S. Dept. of Energy, Available Online at htt12s://www.stan dards.doe.gov/standards- documents/ I 000/1084-bhdbk-1995/@@images/file, Sep. 1995, 54 pages.
Medical Electrical Equipment—Part 1: General Requirements for Safety, British Standard, BS EN 60601-1:1990-BS5724-1:1989, Mar. 1979, 200 pages.
Summary of Safety and Effectiveness, Medtronic InterStim System for Urinary Control, Apr. 15, 1999, pp. 1-18.
The Advanced Bionics PRECISION™ Spinal Cord Stimulator System, Advanced Bionics Corporation, Apr. 27, 2004, pp. 1-18.
UL Standard for Safety for Medical and Dental Equipment, UL 544, 4th edition, Dec. 30, 1998, 128 pages.
Barnhart et al., “A Fixed-Rate Rechargeable Cardiac Pacemaker”, APL Technical Digest, Jan.-Feb. 1970, pp. 2-9.
Benditt et al., “A Combined Atrial/Ventricular Lead for Permanent Dual-Chamber Cardiac Pacing Applications”, Chest, vol. 83, No. 6, Jun. 1983, pp. 929-931.
Boiocchi et al., “Self-Calibration in High Speed Current Steering Cmos D/A Converters”, Advanced A-D and D-A Conversion Techniques and their Applications, Second International Conference on Cambridge, Jul. 1994, pp. 148-152.
Bosch et al., “Sacral (S3) Segmental Nerve Stimulation as a Treatment for Urge Incontinence in Patients with Detrusor Instability: Results of Chronic Electrical Stimulation Using an Implantable Neural Prosthesis”, The Journal of Urology, vol. 154, No. 2, Aug. 1995, pp. 504-507.
Boyce et al., “Research Related to the Development of an Artificial Electrical Stimulator for the Paralyzed Human Bladder: a Review”, The Journal of Urology, vol. 91, No. 1, Jan. 1964, pp. 41-51.
Bradley et al., “Further Experience With the Radio Transmitter Receiver Unit for the Neurogenic Bladder”, Journal of Neurosurgery, vol. 20, No. 11, Nov. 1963, pp. 953-960.
Broggi et al., “Electrical Stimulation of the Gasserian Ganglion for Facial Pain: Preliminary Results”, Acta Neurochirurgica, vol. 39, 1987, pp. 144-146.
Cameron et al., “Effects of Posture on Stimulation Parameters in Spinal Cord Stimulation”, Neuromodulation, vol. 1, No. 4, Oct. 1998, pp. 177-183.
Connelly et al., “Atrial Pacing Leads Following Open Heart Surgery: Active or Passive Fixation?”, Pacing and Clinical Electrophysiology, vol. 20, No. 10, Oct. 1997, pp. 2429-2433.
Fischell , “The Development of Implantable Medical Devices at the Applied Physics Laboratory”, Johns Hopkins APL Technical Digest, vol. 13 No. 1, 1992, pp. 233-243.
Gaunt et al., “Control of Urinary Bladder Function With Devices: Successes and Failures”, Progress in Brain Research, vol. 152, 2006, pp. 1-24.
Ghovanloo et al., “A Small Size Large Voltage Compliance Programmable Current Source for Biomedical Implantable Microstimulators”, Proceedings of the 25th Annual International Conference of the IEEE EMBS, Sep. 17-21, 2003, pp. 1979-1982.
Gundason , “A Low-Power ASK Demodulator for Inductively Coupled Implantable Electronics”, Solid-State Circuits Conference, Esscirc ″00, Proceedings of the 26RD European, IEEE, Sep. 2000, 4 pages.
Helland , “Technical Improvements to be Achieved by the Year 2000: Leads and Connector Technology”, Rate Adaptive Cardiac Pacing, Springer Verlag, 1993, pp. 279-292.
Hidefjall , “The Pace of Innovation—Patterns of Innovation in the Cardiac Pacemaker Industry”, Linkoping University Press, 1997, 398 pages.
Humayun et al., “A Variable Range Bi-Phasic Current Stimulus Driver Circuitry for an Implantable Retinal Prosthetic Device”, IEEE Journal of Solid-State Circuits,vol. 40, No. 3, Mar. 2005, pp. 763-771.
Ishihara et al., “A Comparative Study of Endocardial Pacemaker Leads”, Cardiovascular Surgery, Nagoya Ekisaikai Hospital, 1st Dept. of Surgery, Nagoya University School of Medicine, 1981, pp. 132-135.
Jonas et al., “Studies on the Feasibility of Urinary Bladder Evacuation by Direct Spinal Cord Stimulation. I. Parameters of Most Effective Stimulation”, Investigative urology, vol. 13, No. 2, 1975, pp. 142-150.
Kakuta et al., “In Vivo Long Term Evaluation of Transcutaneous Energy Transmission for Totally Implantable Artificial Heart”, ASAIO Journal, Mar.-Apr. 2000, pp. 1-2.
Kester et al., “Voltage-to-Frequency Converters”, Available Online at: https://www.analog.com/media/cn/training-seminars/tutorials/MT-028.pdf, 7 pages.
Lazorthes et al., “Chronic Stimulation of the Gasserian Ganglion for Treatment of Atypical Facial Neuralgia”, Pacing and Clinical Electrophysiology, vol. 10, Jan.-Feb. 1987, pp. 257-265.
Lewis et al., “Early Clinical Experience with the Rechargeable Cardiac Pacemaker”, The Annals of Thoracic Surgery, vol. 18, No. 5, Nov. 1974, pp. 490-493.
Love et al., “Experimental Testing of a Permanent Rechargeable Cardiac Pacemaker”, The Annals of Thoracic Surgery, vol. 17, No. 2, Feb. 1, 1974, pp. 152-156.
Love , “Pacemaker Troubleshooting and Follow-up”, Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy, Chapter 24, 2007, pp. 1005-1062.
Madigan et al., “Difficulty of Extraction of Chronically Implanted Tined Ventricular Endocardial Leads”, Journal of the American College of Cardiology, vol. 3, No. 3, Mar. 1984, pp. 724-731.
Meglio , “Percutaneously Implantable Chronic Electrode for Radiofrequency Stimulation of the Gasserian Ganglion. A Perspective in the Management of Trigeminal Pain”, Acta Neurochirurgica, vol. 33, 1984, pp. 521-525.
Meyerson , “Alleviation of Atypical Trigeminal Pain by Stimulation of the Gasserian Ganglion via an Implanted Electrode”, Acta Neurochirurgica Suppiementum , vol. 30, 1980, pp. 303-309.
Mitamura et al., “Development of Transcutaneous Energy Transmission System”, Available Online at https://www.researchgate.net/publication/312810915 Ch.28, Jan. 1988, pp. 265-270.
Nakamura et al., “Biocompatibility and Practicality Evaluations of Transcutaneous Energy Transmission Unit for the Totally Implantable Artifical Heart System”, Journal of Artificial Organs, vol. 27, No. 2, 1998, pp. 347-351.
Nashold et al., “Electromicturition in Paraplegia. Implantation of a Spinal Neuroprosthesis”, Arch Surg., vol. 104, Feb. 1972, pp. 195-202.
Painter et al., “Implantation of an Endocardial Tined Lead to Prevent Early Dislodgement”, The Journal of Thoracic and Cardiovascular Surgery, vol. 77, No. 2, Feb. 1979, pp. 249-251.
Perez , “Lead-Acid Battery State of Charge vs. Voltage”, Available Online at http://www.rencobattery.com/resources/SOC vs-Voltage.pdf, Aug.-Sep. 1993, 5 pages.
Schaldach et al., “A Long-Lived, Reliable, Rechargeable Cardiac Pacemaker”, Engineering in Medicine, vol. 1: Advances in Pacemaker Technology, 1975, 34 pages.
Scheuer-Leeser et al., “Polyurethane Leads: Facts and Controversy”, PACE, vol. 6, Mar.-Apr. 1983, pp. 454-458.
Sivaprakasam et al., “A Variable Range Bi-Phasic Current Stimulus Driver Circuitry for an Implantable Retinal Prosthetic Device”, IEEE Journal of Solid-State Circuits, IEEE Service Center, Piscataway, NJ, USA, vol. 40, No. 3, Mar. 1, 2005, pp. 763-771.
Smith , “Changing Standards for Medical Equipment”, UL 544 and UL 187 vs. UL 2601 (“Smith”), 2002, 8 pages.
Tanagho et al., “Bladder Pacemaker: Scientific Basis and Clinical Future”, Urology, vol. 20, No. 6, Dec. 1982, pp. 614-619.
Tanagho , “Neuromodulation and Neurostimulation: Overview and Future Potential”, Translational Androl Urol, vol. 1, No. 1, 2012, pp. 44-49.
Torres et al., “Electrostatic Energy-Harvesting and Battery-Charging CMOS System Prototype”, Available Online at:http://rincon mora.gatech.edu/12ublicat/jrnls/tcasi09_hrv_sys.pdf, pp. 1-10.
Van Paemel , “High-Efficiency Transmission for Medical Implants”, IEEE Solid-State Circuits Magazine, vol. 3, No. 1, Jan. 1, 2011, pp. 47-59.
Wang et al., “A 140-dB CMRR Low-Noise Instrumentation Amplifier for Neural Signal Sensing”, Circuits and Systems, 2006. APCCAS 2006, IEEE Asia Pacific Conference on IEEE, Piscataway, NZ, USA, Dec. 1, 2006, pp. 696-699.
Young , “Electrical Stimulation of the Trigeminal Nerve Root for the Treatment of Chronic Facial Pain”, Journal of Neurosurgery, vol. 83, No. 1, Jul. 1995, pp. 72-78.
Related Publications (1)
Number Date Country
20200179702 A1 Jun 2020 US
Provisional Applications (1)
Number Date Country
61788871 Mar 2013 US
Divisions (2)
Number Date Country
Parent 15980642 May 2018 US
Child 16792102 US
Parent 14217321 Mar 2014 US
Child 15263046 US
Continuations (1)
Number Date Country
Parent 15263046 Sep 2016 US
Child 15980642 US